NAVB News and Press, Navidea Biopharmaceuticals Inc. From 05/12/22

Conference Call to be held Thursday, May 12, 2022 at 5:00 pm (EDT) Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutic...

AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...

Conference Call to be Held on Thursday, May 12, 2022 at 5:00 p.m. (EDT) Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherap...

Navidea Biopharmaceuticals (NYSE:NAVB) reported preliminary results from an ongoing phase 2b study of imaging agent Tc99m Tilmanocept. The main goal of the trial, dubbed NAV3-32, is to assess the relationship between joint-specific tilmanocept uptake values and the pathobi...

Data support hypothesis that Tc99m tilmanocept imaging can differentiate fibroid pathotype of rheumatoid arthritis from non-fibroid pathotypes Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused o...

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the results of an updated third-party asset valuation of its...

What To Know About Buying Penny Stocks on April 19th With another day of buying penny stocks here, there is a lot for investors to know. During early morning trading, we saw gainers like Sharps Technology Inc. ( NASDAQ: STSS ) and Navidea Biopharmaceuticals Inc. ( NYSE: NAVB ) g...

Navidea Biopharmaceuticals (NYSE:NAVB) said it received a Notice of Allowance for a U.S. patent application for diagnosis and treatment of leishmaniasis, a type of parasitic disease. Leishmaniasis is caused by infection with Leishmania parasites, which are spread via the bite of phleboto...

Decision of Grant given in Japan for separate patent application covering targeted delivery of payloads attached to the Manocept platform Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the...

Navidea Biopharma (NYSE:NAVB) stock rose +16.3% post market after it said India approved its Lymphoaim imaging (Tc99m tilmanocept) in patients with breast cancer, melanoma, or localized squamous cell carcinoma of the oral cavity. Tc99m tilmanocept is designed to ...